Loading...

Owen Wolkowitz, MD

TitleProfessor
InstitutionUniversity of California San Francisco
DepartmentPsychiatry
Address401 Parnassus Ave, LangPorter
San Francisco CA 94143
Phone415-476-7433
vCardDownload vCard

    Collapse Biography 
    Collapse Education and Training
    University of Maryland, Baltimore, MDM.D.1979School of Medicine
    Stanford University, Stanford, CAResidency1983Psychaitry
    National Institute of Mental Health, Bethesda, MDFellowship1986Psychopharmacology
    Collapse Awards and Honors
    UCSF2016J. Elliot Royer Award (Academic Psychiatrist)
    Castle Connolly Medical Ltd.2006  - 2017"America's Top Doctors" citation
    International Society of Psychoneuroendocrinology1992Curt P. Richter Prize in Psychoneuroendocrinology
    Woodward/White, Inc., publ.)1994  - 2017"Best Doctors in America" citation

    Collapse Research 
    Collapse Research Activities and Funding
    Cell Aging in Major Depression
    NIH/NIMH R01MH083784Jul 1, 2008 - Feb 29, 2020
    Role: Principal Investigator
    Neurosteroids and acute Alcohol Intoxication in Humans
    NIH/NIAAA R01AA013929May 1, 2004 - Mar 31, 2010
    Role: Principal Investigator
    ALPRAZOLAM - NEUROLEPTIC TREATMENT IN SCHIZOPHRENIA
    NIH/NIMH R29MH043612Sep 30, 1987 - Aug 31, 1993
    Role: Principal Investigator
    General Clinical Research Center
    NIH/NCRR M01RR000079Dec 1, 1974 - Mar 31, 2009
    Role: Co-Investigator

    Collapse ORNG Applications 
    Collapse Clinical Trials
    Collapse Global Health
    Collapse Websites
    Collapse In The News
    Collapse Featured Videos

    Collapse Bibliographic 
    Collapse Publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help.
    List All   |   Timeline
    1. Hernandez NV, Ramirez JL, Khetani SA, Spaulding KA, Gasper WJ, Hiramoto J, Lindqvist D, Wolkowitz OM, Hills NK, Grenon SM, Zahner GJ. Depression severity is associated with increased inflammation in veterans with peripheral artery disease. Vasc Med. 2018 Jul 01; 1358863X18787640. PMID: 30035700.
      View in: PubMed
    2. Wolkowitz OM. Accelerated biological aging in serious mental disorders. World Psychiatry. 2018 Jun; 17(2):144-145. PMID: 29856570.
      View in: PubMed
    3. Arya S, Lee S, Zahner GJ, Cohen BE, Hiramoto J, Wolkowitz OM, Khakharia A, Binney ZO, Grenon SM. The association of comorbid depression with mortality and amputation in veterans with peripheral artery disease. J Vasc Surg. 2018 Mar 24. PMID: 29588133.
      View in: PubMed
    4. Mellon SH, Gautam A, Hammamieh R, Jett M, Wolkowitz OM. Metabolism, Metabolomics, and Inflammation in Posttraumatic Stress Disorder. Biol Psychiatry. 2018 May 15; 83(10):866-875. PMID: 29628193.
      View in: PubMed
    5. Tymofiyeva O, Henje Blom E, Ho TC, Connolly CG, Lindqvist D, Wolkowitz OM, Lin J, LeWinn KZ, Sacchet MD, Han LKM, Yuan JP, Bhandari SP, Xu D, Yang TT. High levels of mitochondrial DNA are associated with adolescent brain structural hypoconnectivity and increased anxiety but not depression. J Affect Disord. 2018 May; 232:283-290. PMID: 29500956.
      View in: PubMed
    6. Lindqvist D, Wolkowitz OM, Picard M, Ohlsson L, Bersani FS, Fernström J, Westrin Å, Hough CM, Lin J, Reus VI, Epel ES, Mellon SH. Circulating cell-free mitochondrial DNA, but not leukocyte mitochondrial DNA copy number, is elevated in major depressive disorder. Neuropsychopharmacology. 2018 Jan 30. PMID: 29453441.
      View in: PubMed
    7. Lindqvist D, Mellon SH, Dhabhar FS, Yehuda R, Grenon SM, Flory JD, Bierer LM, Abu-Amara D, Coy M, Makotkine I, Reus VI, Aschbacher K, Bersani FS, Marmar CR, Wolkowitz OM. Increased circulating blood cell counts in combat-related PTSD: Associations with inflammation and PTSD severity. Psychiatry Res. 2017 Dec; 258:330-336. PMID: 28942957.
      View in: PubMed
    8. Aschbacher K, Mellon SH, Wolkowitz OM, Henn-Haase C, Yehuda R, Flory JD, Bierer LM, Abu-Amara D, Marmar CR, Mueller SG. Posttraumatic stress disorder, symptoms, and white matter abnormalities among combat-exposed veterans. Brain Imaging Behav. 2017 Aug 19. PMID: 28823023.
      View in: PubMed
    9. Hammamieh R, Chakraborty N, Gautam A, Muhie S, Yang R, Donohue D, Kumar R, Daigle BJ, Zhang Y, Amara DA, Miller SA, Srinivasan S, Flory J, Yehuda R, Petzold L, Wolkowitz OM, Mellon SH, Hood L, Doyle FJ, Marmar C, Jett M. Whole-genome DNA methylation status associated with clinical PTSD measures of OIF/OEF veterans. Transl Psychiatry. 2017 Jul 11; 7(7):e1169. PMID: 28696412.
      View in: PubMed
    10. Fair B, Mellon SH, Epel ES, Lin J, Révész D, Verhoeven JE, Penninx BW, Reus VI, Rosser R, Hough CM, Mahan L, Burke HM, Blackburn EH, Wolkowitz OM. Telomere length is inversely correlated with urinary stress hormone levels in healthy controls but not in un-medicated depressed individuals-preliminary findings. J Psychosom Res. 2017 Aug; 99:177-180. PMID: 28712425.
      View in: PubMed
    11. Steenkamp LR, Hough CM, Reus VI, Jain FA, Epel ES, James SJ, Morford AE, Mellon SH, Wolkowitz OM, Lindqvist D. Severity of anxiety- but not depression- is associated with oxidative stress in Major Depressive Disorder. J Affect Disord. 2017 09; 219:193-200. PMID: 28564628.
      View in: PubMed
    12. Blessing EM, Reus V, Mellon SH, Wolkowitz OM, Flory JD, Bierer L, Lindqvist D, Dhabhar F, Li M, Qian M, Abu-Amara D, Galatzer-Levy I, Yehuda R, Marmar CR. Biological predictors of insulin resistance associated with posttraumatic stress disorder in young military veterans. Psychoneuroendocrinology. 2017 Aug; 82:91-97. PMID: 28521179.
      View in: PubMed
    13. Verhoeven JE, Révész D, Picard M, Epel EE, Wolkowitz OM, Matthews KA, Penninx BWJH, Puterman E. Depression, telomeres and mitochondrial DNA: between- and within-person associations from a 10-year longitudinal study. Mol Psychiatry. 2018 Apr; 23(4):850-857. PMID: 28348385.
      View in: PubMed
    14. Hough CM, Lindqvist D, Epel ES, Denis MS, Reus VI, Bersani FS, Rosser R, Mahan L, Burke HM, Wolkowitz OM, Mellon SH. Higher serum DHEA concentrations before and after SSRI treatment are associated with remission of major depression. Psychoneuroendocrinology. 2017 Mar; 77:122-130. PMID: 28038403.
      View in: PubMed
    15. Lindqvist D, Dhabhar FS, James SJ, Hough CM, Jain FA, Bersani FS, Reus VI, Verhoeven JE, Epel ES, Mahan L, Rosser R, Wolkowitz OM, Mellon SH. Oxidative stress, inflammation and treatment response in major depression. Psychoneuroendocrinology. 2017 Feb; 76:197-205. PMID: 27960139.
      View in: PubMed
    16. Verhoeven JE, Lin J, Révész D, Wolkowitz OM, Penninx BW. Unresolved Issues in Longitudinal Telomere Length Research: Response to Susser et al. Am J Psychiatry. 2016 11 01; 173(11):1147-1149. PMID: 27798998.
      View in: PubMed
    17. Wolkowitz OM, Jeste DV, Martin AS, Lin J, Daly RE, Reuter C, Kraemer H. Leukocyte telomere length: Effects of schizophrenia, age, and gender. J Psychiatr Res. 2017 02; 85:42-48. PMID: 27835738.
      View in: PubMed
    18. Lindqvist D, Dhabhar FS, Mellon SH, Yehuda R, Grenon SM, Flory JD, Bierer LM, Abu-Amara D, Coy M, Makotkine I, Reus VI, Bersani FS, Marmar CR, Wolkowitz OM. Increased pro-inflammatory milieu in combat related PTSD - A new cohort replication study. Brain Behav Immun. 2017 Jan; 59:260-264. PMID: 27638184.
      View in: PubMed
    19. Darrow SM, Verhoeven JE, Révész D, Lindqvist D, Penninx BW, Delucchi KL, Wolkowitz OM, Mathews CA. The Association Between Psychiatric Disorders and Telomere Length: A Meta-Analysis Involving 14,827 Persons. Psychosom Med. 2016 Sep; 78(7):776-87. PMID: 27359174; PMCID: PMC5003712 [Available on 09/01/17].
    20. Jin RO, Mason S, Mellon SH, Epel ES, Reus VI, Mahan L, Rosser RL, Hough CM, Burke HM, Mueller SG, Wolkowitz OM. Cortisol/DHEA ratio and hippocampal volume: A pilot study in major depression and healthy controls. Psychoneuroendocrinology. 2016 Oct; 72:139-46. PMID: 27428086.
      View in: PubMed
    21. Hough CM, Bersani FS, Mellon SH, Epel ES, Reus VI, Lindqvist D, Lin J, Mahan L, Rosser R, Burke H, Coetzee J, Nelson JC, Blackburn EH, Wolkowitz OM. Leukocyte telomere length predicts SSRI response in major depressive disorder: A preliminary report. Mol Neuropsychiatry. 2016 Jul; 2(2):88-96. PMID: 27429957.
      View in: PubMed
    22. Lee EE, Eyler LT, Wolkowitz OM, Martin AS, Reuter C, Kraemer H, Jeste DV. Elevated plasma F2-isoprostane levels in schizophrenia. Schizophr Res. 2016 10; 176(2-3):320-326. PMID: 27318521; PMCID: PMC5026902 [Available on 10/01/17].
    23. Mellon SH, Wolkowitz OM, Schonemann MD, Epel ES, Rosser R, Burke HB, Mahan L, Reus VI, Stamatiou D, Liew CC, Cole SW. Alterations in leukocyte transcriptional control pathway activity associated with major depressive disorder and antidepressant treatment. Transl Psychiatry. 2016 05 24; 6:e821. PMID: 27219347.
      View in: PubMed
    24. Bersani FS, Wolkowitz OM, Milush JM, Sinclair E, Eppling L, Aschbacher K, Lindqvist D, Yehuda R, Flory J, Bierer LM, Matokine I, Abu-Amara D, Reus VI, Coy M, Hough CM, Marmar CR, Mellon SH. A population of atypical CD56(-)CD16(+) natural killer cells is expanded in PTSD and is associated with symptom severity. Brain Behav Immun. 2016 Aug; 56:264-70. PMID: 27025668.
      View in: PubMed
    25. Verhoeven JE, van Oppen P, Révész D, Wolkowitz OM, Penninx BW. Depressive and Anxiety Disorders Showing Robust, but Non-Dynamic, 6-Year Longitudinal Association With Short Leukocyte Telomere Length. Am J Psychiatry. 2016 06 01; 173(6):617-24. PMID: 26940806.
      View in: PubMed
    26. Fisher M, Mellon SH, Wolkowitz O, Vinogradov S. Neuroscience-informed Auditory Training in Schizophrenia: A Final Report of the Effects on Cognition and Serum Brain-Derived Neurotrophic Factor. Schizophr Res Cogn. 2016 Mar 01; 3:1-7. PMID: 26705516.
      View in: PubMed
    27. Henje Blom E, Han LK, Connolly CG, Ho TC, Lin J, LeWinn KZ, Simmons AN, Sacchet MD, Mobayed N, Luna ME, Paulus M, Epel ES, Blackburn EH, Wolkowitz OM, Yang TT. Peripheral telomere length and hippocampal volume in adolescents with major depressive disorder. Transl Psychiatry. 2015 Nov 10; 5:e676. PMID: 26556285.
      View in: PubMed
    28. Bersani FS, Lindqvist D, Mellon SH, Epel ES, Yehuda R, Flory J, Henn-Hasse C, Bierer LM, Makotkine I, Abu-Amara D, Coy M, Reus VI, Lin J, Blackburn EH, Marmar C, Wolkowitz OM. Association of dimensional psychological health measures with telomere length in male war veterans. J Affect Disord. 2016 Jan 15; 190:537-542. PMID: 26571103.
      View in: PubMed
    29. Bersani FS, Wolkowitz OM, Lindqvist D, Yehuda R, Flory J, Bierer LM, Makotine I, Abu-Amara D, Coy M, Reus VI, Epel ES, Marmar C, Mellon SH. Global arginine bioavailability, a marker of nitric oxide synthetic capacity, is decreased in PTSD and correlated with symptom severity and markers of inflammation. Brain Behav Immun. 2016 Feb; 52:153-160. PMID: 26515034.
      View in: PubMed
    30. Mueller SG, Ng P, Neylan T, Mackin S, Wolkowitz O, Mellon S, Yan X, Flory J, Yehuda R, Marmar CR, Weiner MW. Evidence for disrupted gray matter structural connectivity in posttraumatic stress disorder. Psychiatry Res. 2015 Nov 30; 234(2):194-201. PMID: 26419357.
      View in: PubMed
    31. Bersani FS, Lindqvist D, Mellon SH, Penninx BW, Verhoeven JE, Révész D, Reus VI, Wolkowitz OM. Telomerase activation as a possible mechanism of action for psychopharmacological interventions. Drug Discov Today. 2015 Nov; 20(11):1305-9. PMID: 26166813.
      View in: PubMed
    32. Bersani FS, Morley C, Lindqvist D, Epel ES, Picard M, Yehuda R, Flory J, Bierer LM, Makotkine I, Abu-Amara D, Coy M, Reus VI, Lin J, Blackburn EH, Marmar C, Wolkowitz OM, Mellon SH. Mitochondrial DNA copy number is reduced in male combat veterans with PTSD. Prog Neuropsychopharmacol Biol Psychiatry. 2016 Jan 04; 64:10-7. PMID: 26120081.
      View in: PubMed
    33. Eisendrath SJ, Gillung E, Delucchi K, Mathalon DH, Yang TT, Satre DD, Rosser R, Sipe WE, Wolkowitz OM. A Preliminary Study: Efficacy of Mindfulness-Based Cognitive Therapy versus Sertraline as First-line Treatments for Major Depressive Disorder. Mindfulness (N Y). 2015 Jun 01; 6(3):475-482. PMID: 26085853.
      View in: PubMed
    34. Lindqvist D, Epel ES, Mellon SH, Penninx BW, Révész D, Verhoeven JE, Reus VI, Lin J, Mahan L, Hough CM, Rosser R, Bersani FS, Blackburn EH, Wolkowitz OM. Psychiatric disorders and leukocyte telomere length: Underlying mechanisms linking mental illness with cellular aging. Neurosci Biobehav Rev. 2015 Aug; 55:333-64. PMID: 25999120; PMCID: PMC4501875.
    35. Lohr JB, Palmer BW, Eidt CA, Aailaboyina S, Mausbach BT, Wolkowitz OM, Thorp SR, Jeste DV. Is Post-Traumatic Stress Disorder Associated with Premature Senescence? A Review of the Literature. Am J Geriatr Psychiatry. 2015 Jul; 23(7):709-25. PMID: 25959921; PMCID: PMC4568841.
    36. Verhoeven JE, Révész D, van Oppen P, Epel ES, Wolkowitz OM, Penninx BW. Anxiety disorders and accelerated cellular ageing. Br J Psychiatry. 2015 May; 206(5):371-8. PMID: 25657360.
      View in: PubMed
    37. Wolkowitz OM, Mellon SH, Lindqvist D, Epel ES, Blackburn EH, Lin J, Reus VI, Burke H, Rosser R, Mahan L, Mackin S, Yang T, Weiner M, Mueller S. PBMC telomerase activity, but not leukocyte telomere length, correlates with hippocampal volume in major depression. Psychiatry Res. 2015 Apr 30; 232(1):58-64. PMID: 25773002; PMCID: PMC4404215.
    38. Yan X, Lazar M, Shalev AY, Neylan TC, Wolkowitz OM, Brown AD, Henn-Haase C, Yehuda R, Flory JD, Abu-Amara D, Sodickson DK, Marmar CR. WITHDRAWN: Precuneal and amygdala spontaneous activity and functional connectivity in war-zone-related PTSD. Psychiatry Res. 2014 Dec 13. PMID: 25561375.
      View in: PubMed
    39. Judd LL, Schettler PJ, Brown ES, Wolkowitz OM, Sternberg EM, Bender BG, Bulloch K, Cidlowski JA, de Kloet ER, Fardet L, Joëls M, Leung DY, McEwen BS, Roozendaal B, Van Rossum EF, Ahn J, Brown DW, Plitt A, Singh G. Adverse consequences of glucocorticoid medication: psychological, cognitive, and behavioral effects. Am J Psychiatry. 2014 Oct; 171(10):1045-51. PMID: 25272344.
      View in: PubMed
    40. Gotlib IH, LeMoult J, Colich NL, Foland-Ross LC, Hallmayer J, Joormann J, Lin J, Wolkowitz OM. Telomere length and cortisol reactivity in children of depressed mothers. Mol Psychiatry. 2015 May; 20(5):615-20. PMID: 25266121; PMCID: PMC4419149.
    41. Lindqvist D, Mueller S, Mellon SH, Su Y, Epel ES, Reus VI, Rosser R, Mahan L, Mackin RS, Yang TT, Wolkowitz OM. Peripheral antioxidant markers are associated with total hippocampal and CA3/dentate gyrus volume in MDD and healthy controls-preliminary findings. Psychiatry Res. 2014 Dec 30; 224(3):168-74. PMID: 25266915; PMCID: PMC4254356.
    42. Verhoeven JE, Révész D, Wolkowitz OM, Penninx BW. Cellular aging in depression: Permanent imprint or reversible process?: An overview of the current evidence, mechanistic pathways, and targets for interventions. Bioessays. 2014 Oct; 36(10):968-78. PMID: 25143317.
      View in: PubMed
    43. Chen SH, Epel ES, Mellon SH, Lin J, Reus VI, Rosser R, Kupferman E, Burke H, Mahan L, Blackburn EH, Wolkowitz OM. Adverse childhood experiences and leukocyte telomere maintenance in depressed and healthy adults. J Affect Disord. 2014 Dec; 169:86-90. PMID: 25173430; PMCID: PMC4172492.
    44. Lindqvist D, Wolkowitz OM, Mellon S, Yehuda R, Flory JD, Henn-Haase C, Bierer LM, Abu-Amara D, Coy M, Neylan TC, Makotkine I, Reus VI, Yan X, Taylor NM, Marmar CR, Dhabhar FS. Proinflammatory milieu in combat-related PTSD is independent of depression and early life stress. Brain Behav Immun. 2014 Nov; 42:81-8. PMID: 24929195.
      View in: PubMed
    45. Révész D, Verhoeven JE, Milaneschi Y, de Geus EJ, Wolkowitz OM, Penninx BW. Dysregulated physiological stress systems and accelerated cellular aging. Neurobiol Aging. 2014 Jun; 35(6):1422-30. PMID: 24439483.
      View in: PubMed
    46. Verhoeven JE, Révész D, Epel ES, Lin J, Wolkowitz OM, Penninx BW. Major depressive disorder and accelerated cellular aging: results from a large psychiatric cohort study. Mol Psychiatry. 2014 Aug; 19(8):895-901. PMID: 24217256.
      View in: PubMed
    47. Connolly CG, Wu J, Ho TC, Hoeft F, Wolkowitz O, Eisendrath S, Frank G, Hendren R, Max JE, Paulus MP, Tapert SF, Banerjee D, Simmons AN, Yang TT. Resting-state functional connectivity of subgenual anterior cingulate cortex in depressed adolescents. Biol Psychiatry. 2013 Dec 15; 74(12):898-907. PMID: 23910949; PMCID: PMC4103629.
    48. Ho TC, Wu J, Shin DD, Liu TT, Tapert SF, Yang G, Connolly CG, Frank GK, Max JE, Wolkowitz O, Eisendrath S, Hoeft F, Banerjee D, Hood K, Hendren RL, Paulus MP, Simmons AN, Yang TT. Altered cerebral perfusion in executive, affective, and motor networks during adolescent depression. J Am Acad Child Adolesc Psychiatry. 2013 Oct; 52(10):1076-1091.e2. PMID: 24074474; PMCID: PMC3825460.
    49. Yan X, Brown AD, Lazar M, Cressman VL, Henn-Haase C, Neylan TC, Shalev A, Wolkowitz OM, Hamilton SP, Yehuda R, Sodickson DK, Weiner MW, Marmar CR. Spontaneous brain activity in combat related PTSD. Neurosci Lett. 2013 Jun 28; 547:1-5. PMID: 23643995.
      View in: PubMed
    50. Shalev I, Entringer S, Wadhwa PD, Wolkowitz OM, Puterman E, Lin J, Epel ES. Stress and telomere biology: a lifespan perspective. Psychoneuroendocrinology. 2013 Sep; 38(9):1835-42. PMID: 23639252; PMCID: PMC3735679.
    51. Aschbacher K, O'Donovan A, Wolkowitz OM, Dhabhar FS, Su Y, Epel E. Good stress, bad stress and oxidative stress: insights from anticipatory cortisol reactivity. Psychoneuroendocrinology. 2013 Sep; 38(9):1698-708. PMID: 23490070; PMCID: PMC4028159.
    52. Jarcho MR, Slavich GM, Tylova-Stein H, Wolkowitz OM, Burke HM. Dysregulated diurnal cortisol pattern is associated with glucocorticoid resistance in women with major depressive disorder. Biol Psychol. 2013 Apr; 93(1):150-8. PMID: 23410758; PMCID: PMC3687535.
    53. Rawdin BJ, Mellon SH, Dhabhar FS, Epel ES, Puterman E, Su Y, Burke HM, Reus VI, Rosser R, Hamilton SP, Nelson JC, Wolkowitz OM. Dysregulated relationship of inflammation and oxidative stress in major depression. Brain Behav Immun. 2013 Jul; 31:143-52. PMID: 23201587; PMCID: PMC3669232.
    54. Woolley JD, Strobl EV, Shelly WB, Karydas AM, Robin Ketelle RN, Wolkowitz OM, Miller BL, Rankin KP. BDNF serum concentrations show no relationship with diagnostic group or medication status in neurodegenerative disease. Curr Alzheimer Res. 2012 Sep; 9(7):815-21. PMID: 21605064; PMCID: PMC3176995.
    55. O'Donovan A, Tomiyama AJ, Lin J, Puterman E, Adler NE, Kemeny M, Wolkowitz OM, Blackburn EH, Epel ES. Stress appraisals and cellular aging: a key role for anticipatory threat in the relationship between psychological stress and telomere length. Brain Behav Immun. 2012 May; 26(4):573-9. PMID: 22293459; PMCID: PMC3322317.
    56. Tomiyama AJ, O'Donovan A, Lin J, Puterman E, Lazaro A, Chan J, Dhabhar FS, Wolkowitz O, Kirschbaum C, Blackburn E, Epel E. Does cellular aging relate to patterns of allostasis? An examination of basal and stress reactive HPA axis activity and telomere length. Physiol Behav. 2012 Apr 12; 106(1):40-5. PMID: 22138440; PMCID: PMC3361080.
    57. Aschbacher K, Epel E, Wolkowitz OM, Prather AA, Puterman E, Dhabhar FS. Maintenance of a positive outlook during acute stress protects against pro-inflammatory reactivity and future depressive symptoms. Brain Behav Immun. 2012 Feb; 26(2):346-52. PMID: 22119400; PMCID: PMC4030538.
    58. Aschbacher K, Chen Q, Varga M, Haddad DJ, Yeghiazarians Y, Epel E, Wolkowitz OM, Springer ML. Higher fasting glucose levels are associated with reduced circulating angiogenic cell migratory capacity among healthy individuals. Am J Cardiovasc Dis. 2012; 2(1):12-9. PMID: 22254209; PMCID: PMC3257152.
    59. Puterman E, O'Donovan A, Adler NE, Tomiyama AJ, Kemeny M, Wolkowitz OM, Epel E. Physical activity moderates effects of stressor-induced rumination on cortisol reactivity. Psychosom Med. 2011 Sep; 73(7):604-11. PMID: 21873586; PMCID: PMC3167008.
    60. Wolkowitz OM, Wolf J, Shelly W, Rosser R, Burke HM, Lerner GK, Reus VI, Nelson JC, Epel ES, Mellon SH. Serum BDNF levels before treatment predict SSRI response in depression. Prog Neuropsychopharmacol Biol Psychiatry. 2011 Aug 15; 35(7):1623-30. PMID: 21749907; PMCID: PMC3159044.
    61. Jeste DV, Wolkowitz OM, Palmer BW. Divergent trajectories of physical, cognitive, and psychosocial aging in schizophrenia. Schizophr Bull. 2011 May; 37(3):451-5. PMID: 21505111; PMCID: PMC3080682.
    62. O'Donovan A, Epel E, Lin J, Wolkowitz O, Cohen B, Maguen S, Metzler T, Lenoci M, Blackburn E, Neylan TC. Childhood trauma associated with short leukocyte telomere length in posttraumatic stress disorder. Biol Psychiatry. 2011 Sep 01; 70(5):465-71. PMID: 21489410; PMCID: PMC3152637.
    63. Wolkowitz OM, Mellon SH, Epel ES, Lin J, Dhabhar FS, Su Y, Reus VI, Rosser R, Burke HM, Kupferman E, Compagnone M, Nelson JC, Blackburn EH. Leukocyte telomere length in major depression: correlations with chronicity, inflammation and oxidative stress--preliminary findings. PLoS One. 2011 Mar 23; 6(3):e17837. PMID: 21448457; PMCID: PMC3063175.
    64. Wolkowitz OM, Mellon SH, Epel ES, Lin J, Reus VI, Rosser R, Burke H, Compagnone M, Nelson JC, Dhabhar FS, Blackburn EH. Resting leukocyte telomerase activity is elevated in major depression and predicts treatment response. Mol Psychiatry. 2012 Feb; 17(2):164-72. PMID: 21242992; PMCID: PMC3130817.
    65. Wolkowitz OM, Reus VI, Mellon SH. Of sound mind and body: depression, disease, and accelerated aging. Dialogues Clin Neurosci. 2011; 13(1):25-39. PMID: 21485744; PMCID: PMC3181963.
    66. Jacobs TL, Epel ES, Lin J, Blackburn EH, Wolkowitz OM, Bridwell DA, Zanesco AP, Aichele SR, Sahdra BK, MacLean KA, King BG, Shaver PR, Rosenberg EL, Ferrer E, Wallace BA, Saron CD. Intensive meditation training, immune cell telomerase activity, and psychological mediators. Psychoneuroendocrinology. 2011 Jun; 36(5):664-81. PMID: 21035949.
      View in: PubMed
    67. Lin J, Kroenke CH, Epel E, Kenna HA, Wolkowitz OM, Blackburn E, Rasgon NL. Greater endogenous estrogen exposure is associated with longer telomeres in postmenopausal women at risk for cognitive decline. Brain Res. 2011 Mar 16; 1379:224-31. PMID: 20965155; PMCID: PMC3057451.
    68. Berger W, Mehra A, Lenoci M, Metzler TJ, Otte C, Tarasovsky G, Mellon SH, Wolkowitz OM, Marmar CR, Neylan TC. Serum brain-derived neurotrophic factor predicts responses to escitalopram in chronic posttraumatic stress disorder. Prog Neuropsychopharmacol Biol Psychiatry. 2010 Oct 01; 34(7):1279-84. PMID: 20643177; PMCID: PMC2939182.
    69. Wolkowitz OM, Epel ES, Reus VI, Mellon SH. Depression gets old fast: do stress and depression accelerate cell aging? Depress Anxiety. 2010 Apr; 27(4):327-38. PMID: 20376837.
      View in: PubMed
    70. Epel ES, Lin J, Dhabhar FS, Wolkowitz OM, Puterman E, Karan L, Blackburn EH. Dynamics of telomerase activity in response to acute psychological stress. Brain Behav Immun. 2010 May; 24(4):531-9. PMID: 20018236; PMCID: PMC2856774.
    71. Lin J, Epel E, Cheon J, Kroenke C, Sinclair E, Bigos M, Wolkowitz O, Mellon S, Blackburn E. Analyses and comparisons of telomerase activity and telomere length in human T and B cells: insights for epidemiology of telomere maintenance. J Immunol Methods. 2010 Jan 31; 352(1-2):71-80. PMID: 19837074; PMCID: PMC3280689.
    72. Wolkowitz OM, Burke H, Epel ES, Reus VI. Glucocorticoids. Mood, memory, and mechanisms. Ann N Y Acad Sci. 2009 Oct; 1179:19-40. PMID: 19906230.
      View in: PubMed
    73. Dhabhar FS, Burke HM, Epel ES, Mellon SH, Rosser R, Reus VI, Wolkowitz OM. Low serum IL-10 concentrations and loss of regulatory association between IL-6 and IL-10 in adults with major depression. J Psychiatr Res. 2009 Jul; 43(11):962-9. PMID: 19552919.
      View in: PubMed
    74. Vinogradov S, Fisher M, Holland C, Shelly W, Wolkowitz O, Mellon SH. Is serum brain-derived neurotrophic factor a biomarker for cognitive enhancement in schizophrenia? Biol Psychiatry. 2009 Sep 15; 66(6):549-53. PMID: 19368899; PMCID: PMC4691262.
    75. O'Donovan A, Lin J, Tillie J, Tillie JM, Dhabhar FS, Wolkowitz OM, Wolkowitz O, Blackburn EH, Blackburn E, Epel ES, Epel E. Pessimism correlates with leukocyte telomere shortness and elevated interleukin-6 in post-menopausal women. Brain Behav Immun. 2009 May; 23(4):446-9. PMID: 19111922; PMCID: PMC2719778.
    76. Maninger N, Wolkowitz OM, Reus VI, Epel ES, Mellon SH. Neurobiological and neuropsychiatric effects of dehydroepiandrosterone (DHEA) and DHEA sulfate (DHEAS). Front Neuroendocrinol. 2009 Jan; 30(1):65-91. PMID: 19063914; PMCID: PMC2725024.
    77. Wolkowitz OM, Epel ES, Mellon S. When blue turns to grey: do stress and depression accelerate cell aging? World J Biol Psychiatry. 2008; 9(1):2-5. PMID: 18273736.
      View in: PubMed
    78. Wolkowitz OM, Lupien SJ, Bigler ED. The "steroid dementia syndrome": a possible model of human glucocorticoid neurotoxicity. Neurocase. 2007 Jun; 13(3):189-200. PMID: 17786779.
      View in: PubMed
    79. Harris DS, Reus VI, Wolkowitz O, Jacob P, Everhart ET, Wilson M, Mendelson JE, Jones RT. Catecholamine response to methamphetamine is related to glucocorticoid levels but not to pleasurable subjective response. Pharmacopsychiatry. 2006 May; 39(3):100-8. PMID: 16721698.
      View in: PubMed
    80. Epel ES, Lin J, Wilhelm FH, Wolkowitz OM, Cawthon R, Adler NE, Dolbier C, Mendes WB, Blackburn EH. Cell aging in relation to stress arousal and cardiovascular disease risk factors. Psychoneuroendocrinology. 2006 Apr; 31(3):277-87. PMID: 16298085.
      View in: PubMed
    81. Harris DS, Reus VI, Wolkowitz OM, Mendelson JE, Jones RT. Repeated psychological stress testing in stimulant-dependent patients. Prog Neuropsychopharmacol Biol Psychiatry. 2005 Jun; 29(5):669-77. PMID: 15913869.
      View in: PubMed
    82. Chao LL, Schuff N, Kramer JH, Du AT, Capizzano AA, O'Neill J, Wolkowitz OM, Jagust WJ, Chui HC, Miller BL, Yaffe K, Weiner MW. Reduced medial temporal lobe N-acetylaspartate in cognitively impaired but nondemented patients. Neurology. 2005 Jan 25; 64(2):282-9. PMID: 15668426; PMCID: PMC1851679.
    83. Wolkowitz OM, Lupien SJ, Bigler E, Levin RB, Canick J. The "steroid dementia syndrome": an unrecognized complication of glucocorticoid treatment. Ann N Y Acad Sci. 2004 Dec; 1032:191-4. PMID: 15677408.
      View in: PubMed
    84. Meieran SE, Reus VI, Webster R, Shafton R, Wolkowitz OM. Chronic pregnenolone effects in normal humans: attenuation of benzodiazepine-induced sedation. Psychoneuroendocrinology. 2004 May; 29(4):486-500. PMID: 14749094.
      View in: PubMed
    85. Ormiston T, Wolkowitz OM, Reus VI, Johnson R, Manfredi F. Hormonal changes with cholesterol reduction: a double-blind pilot study. J Clin Pharm Ther. 2004 Feb; 29(1):71-3. PMID: 14748901.
      View in: PubMed
    86. Ormiston T, Wolkowitz OM, Reus VI, Manfredi F. Behavioral implications of lowering cholesterol levels: a double-blind pilot study. Psychosomatics. 2003 Sep-Oct; 44(5):412-4. PMID: 12954916.
      View in: PubMed
    87. Wolkowitz OM, Reus VI. Neurotransmitters, neurosteroids and neurotrophins: new models of the pathophysiology and treatment of depression. World J Biol Psychiatry. 2003 Jul; 4(3):98-102. PMID: 12872201.
      View in: PubMed
    88. Harris DS, Reus VI, Wolkowitz OM, Mendelson JE, Jones RT. Altering cortisol level does not change the pleasurable effects of methamphetamine in humans. Neuropsychopharmacology. 2003 Sep; 28(9):1677-84. PMID: 12813474.
      View in: PubMed
    89. Wolkowitz OM, Kramer JH, Reus VI, Costa MM, Yaffe K, Walton P, Raskind M, Peskind E, Newhouse P, Sack D, De Souza E, Sadowsky C, Roberts E. DHEA treatment of Alzheimer's disease: a randomized, double-blind, placebo-controlled study. Neurology. 2003 Apr 08; 60(7):1071-6. PMID: 12682308.
      View in: PubMed
    90. Seeley WW, Turetsky N, Reus VI, Wolkowitz OM. Benzodiazepines in schizophrenia: prefrontal cortex atrophy predicts clinical response to alprazolam augmentation. World J Biol Psychiatry. 2002 Oct; 3(4):221-4. PMID: 12516314.
      View in: PubMed
    91. Marco EJ, Wolkowitz OM, Vinogradov S, Poole JH, Lichtmacher J, Reus VI. Double-blind antiglucocorticoid treatment in schizophrenia and schizoaffective disorder: a pilot study. World J Biol Psychiatry. 2002 Jul; 3(3):156-61. PMID: 12478881.
      View in: PubMed
    92. Kahn AJ, Halloran B, Wolkowitz O, Brizendine L. Dehydroepiandrosterone supplementation and bone turnover in middle-aged to elderly men. J Clin Endocrinol Metab. 2002 Apr; 87(4):1544-9. PMID: 11932279.
      View in: PubMed
    93. Schuff N, Capizzano AA, Du AT, Amend DL, O'Neill J, Norman D, Kramer J, Jagust W, Miller B, Wolkowitz OM, Yaffe K, Weiner MW. Selective reduction of N-acetylaspartate in medial temporal and parietal lobes in AD. Neurology. 2002 Mar 26; 58(6):928-35. PMID: 11914410; PMCID: PMC1851674.
    94. Reus VI, Wolkowitz OM. Antiglucocorticoid drugs in the treatment of depression. Expert Opin Investig Drugs. 2001 Oct; 10(10):1789-96. PMID: 11772285.
      View in: PubMed
    95. Neylan TC, Canick JD, Hall SE, Reus VI, Sapolsky RM, Wolkowitz OM. Cortisol levels predict cognitive impairment induced by electroconvulsive therapy. Biol Psychiatry. 2001 Sep 01; 50(5):331-6. PMID: 11543735.
      View in: PubMed
    96. Wolkowitz OM, Epel ES, Reus VI. Stress hormone-related psychopathology: pathophysiological and treatment implications. World J Biol Psychiatry. 2001 Jul; 2(3):115-43. PMID: 12587196.
      View in: PubMed
    97. Harris DS, Wolkowitz OM, Reus VI. Movement disorder, memory, psychiatric symptoms and serum DHEA levels in schizophrenic and schizoaffective patients. World J Biol Psychiatry. 2001 Apr; 2(2):99-102. PMID: 12587192.
      View in: PubMed
    98. Heinz A, Weingartner H, George D, Hommer D, Wolkowitz OM, Linnoila M. Severity of depression in abstinent alcoholics is associated with monoamine metabolites and dehydroepiandrosterone-sulfate concentrations. Psychiatry Res. 1999 Dec 20; 89(2):97-106. PMID: 10646828.
      View in: PubMed
    99. Wolkowitz OM, Reus VI. Treatment of depression with antiglucocorticoid drugs. Psychosom Med. 1999 Sep-Oct; 61(5):698-711. PMID: 10511017.
      View in: PubMed
    100. Costa MM, Reus VI, Wolkowitz OM, Manfredi F, Lieberman M. Estrogen replacement therapy and cognitive decline in memory-impaired post-menopausal women. Biol Psychiatry. 1999 Jul 15; 46(2):182-8. PMID: 10418692.
      View in: PubMed
    101. Wolkowitz OM, Reus VI, Chan T, Manfredi F, Raum W, Johnson R, Canick J. Antiglucocorticoid treatment of depression: double-blind ketoconazole. Biol Psychiatry. 1999 Apr 15; 45(8):1070-4. PMID: 10386195.
      View in: PubMed
    102. Wolkowitz OM, Reus VI, Keebler A, Nelson N, Friedland M, Brizendine L, Roberts E. Double-blind treatment of major depression with dehydroepiandrosterone. Am J Psychiatry. 1999 Apr; 156(4):646-9. PMID: 10200751.
      View in: PubMed
    103. Knutson B, Wolkowitz OM, Cole SW, Chan T, Moore EA, Johnson RC, Terpstra J, Turner RA, Reus VI. Selective alteration of personality and social behavior by serotonergic intervention. Am J Psychiatry. 1998 Mar; 155(3):373-9. PMID: 9501748.
      View in: PubMed
    104. Reid MS, Ho LB, Tolliver BK, Wolkowitz OM, Berger SP. Partial reversal of stress-induced behavioral sensitization to amphetamine following metyrapone treatment. Brain Res. 1998 Feb 02; 783(1):133-42. PMID: 9479062.
      View in: PubMed
    105. Wolkowitz OM, Reus VI, Canick J, Levin B, Lupien S. Glucocorticoid medication, memory and steroid psychosis in medical illness. Ann N Y Acad Sci. 1997 Aug 14; 823:81-96. PMID: 9292035.
      View in: PubMed
    106. Wolkowitz OM, Reus VI, Roberts E, Manfredi F, Chan T, Raum WJ, Ormiston S, Johnson R, Canick J, Brizendine L, Weingartner H. Dehydroepiandrosterone (DHEA) treatment of depression. Biol Psychiatry. 1997 Feb 01; 41(3):311-8. PMID: 9024954.
      View in: PubMed
    107. Knutson B, Cole S, Wolkowitz O, Reus V, Chan T, Moore E. Serotonergic intervention increases affiliative behavior in humans. Ann N Y Acad Sci. 1997 Jan 15; 807:492-3. PMID: 9071379.
      View in: PubMed
    108. Reus VI, Wolkowitz OM, Frederick S. Antiglucocorticoid treatments in psychiatry. Psychoneuroendocrinology. 1997; 22 Suppl 1:S121-4. PMID: 9264158.
      View in: PubMed
    109. Hoff AL, Faustman WO, Wieneke M, Espinoza S, Costa M, Wolkowitz O, Csernansky JG. The effects of clozapine on symptom reduction, neurocognitive function, and clinical management in treatment-refractory state hospital schizophrenic inpatients. Neuropsychopharmacology. 1996 Oct; 15(4):361-9. PMID: 8887990.
      View in: PubMed
    110. Wolkowitz OM, Reus VI, Manfredi F, Chan T, Ormiston S, Johnson R. Dexamethasone for depression. Am J Psychiatry. 1996 Aug; 153(8):1112; author reply 1112-3. PMID: 8678190.
      View in: PubMed
    111. Grasing K, Murphy MG, Lin J, Swigar M, Freedholm D, Clarke L, Zhang J, Wolkowitz OM, Weingartner H, Putnam K, Seibold JR. Human pharmacokinetics and tolerability of L-365,260, a novel cholecystokinin-B antagonist. J Clin Pharmacol. 1996 Apr; 36(4):292-300. PMID: 8728342.
      View in: PubMed
    112. Wolkowitz OM, Reus VI, Roberts E, Manfredi F, Chan T, Ormiston S, Johnson R, Canick J, Brizendine L, Weingartner H. Antidepressant and cognition-enhancing effects of DHEA in major depression. Ann N Y Acad Sci. 1995 Dec 29; 774:337-9. PMID: 8597481.
      View in: PubMed
    113. Roy A, Wolkowitz OM, Bissette G, Nemeroff CB. Differences in CSF concentrations of thyrotropin-releasing hormone in depressed patients and normal subjects: negative findings. Am J Psychiatry. 1994 Apr; 151(4):600-2. PMID: 7511876.
      View in: PubMed
    114. Wolkowitz OM. Prospective controlled studies of the behavioral and biological effects of exogenous corticosteroids. Psychoneuroendocrinology. 1994; 19(3):233-55. PMID: 7515507.
      View in: PubMed
    115. Rapaport MH, Wolkowitz O, Kelsoe JR, Pato C, Konicki PE, Pickar D. Beneficial effects of nalmefene augmentation in neuroleptic-stabilized schizophrenic patients. Neuropsychopharmacology. 1993 Sep; 9(2):111-5. PMID: 8105790.
      View in: PubMed
    116. Wolkowitz OM. Rational polypharmacy in schizophrenia. Ann Clin Psychiatry. 1993 Jun; 5(2):79-90. PMID: 8348207.
      View in: PubMed
    117. Wolkowitz OM, Weingartner H, Rubinow DR, Jimerson D, Kling M, Berretini W, Thompson K, Breier A, Doran A, Reus VI. Steroid modulation of human memory: biochemical correlates. Biol Psychiatry. 1993 May 15; 33(10):744-6. PMID: 8102553.
      View in: PubMed
    118. Wolkowitz OM, Reus VI, Manfredi F, Ingbar J, Brizendine L, Weingartner H. Ketoconazole administration in hypercortisolemic depression. Am J Psychiatry. 1993 May; 150(5):810-2. PMID: 8480829.
      View in: PubMed
    119. Wolkowitz OM, Coppola R, Breier A, Doran AR, Rubinow DR, Berrettini WH, Kling MA, Pickar D. Quantitative electroencephalographic correlates of steroid administration in man. Neuropsychobiology. 1993; 27(4):224-30. PMID: 8232843.
      View in: PubMed
    120. Goldstein DS, Breier A, Wolkowitz OM, Pickar D, Lenders JW. Plasma levels of catecholamines and corticotrophin during acute glucopenia induced by 2-deoxy-D-glucose in normal man. Clin Auton Res. 1992 Dec; 2(6):359-66. PMID: 1337845.
      View in: PubMed
    121. Wolkowitz OM, Reus VI, Manfredi F, Ingbar J, Brizendine L. Antiglucocorticoid strategies in hypercortisolemic states. Psychopharmacol Bull. 1992; 28(3):247-51. PMID: 1480727.
      View in: PubMed
    122. Wolkowitz OM, Turetsky N, Reus VI, Hargreaves WA. Benzodiazepine augmentation of neuroleptics in treatment-resistant schizophrenia. Psychopharmacol Bull. 1992; 28(3):291-5. PMID: 1362277.
      View in: PubMed
    123. Wolkowitz OM, Pickar D. Benzodiazepines in the treatment of schizophrenia: a review and reappraisal. Am J Psychiatry. 1991 Jun; 148(6):714-26. PMID: 1674645.
      View in: PubMed
    124. Deicken RF, Reus VI, Manfredi L, Wolkowitz OM. MRI deep white matter hyperintensity in a psychiatric population. Biol Psychiatry. 1991 May 01; 29(9):918-22. PMID: 2049490.
      View in: PubMed
    125. Wolkowitz OM, Bartko JJ, Pickar D. Drug trials and heterogeneity in schizophrenia: the mean is not the end. Biol Psychiatry. 1990 Dec 15; 28(12):1021-5. PMID: 1981151.
      View in: PubMed
    126. Breier A, Wolkowitz OM, Roy A, Potter WZ, Pickar D. Plasma norepinephrine in chronic schizophrenia. Am J Psychiatry. 1990 Nov; 147(11):1467-70. PMID: 2221157.
      View in: PubMed
    127. Wolkowitz OM, Reus VI, Weingartner H, Thompson K, Breier A, Doran A, Rubinow D, Pickar D. Cognitive effects of corticosteroids. Am J Psychiatry. 1990 Oct; 147(10):1297-303. PMID: 2399996.
      View in: PubMed
    128. Wolkowitz OM, Rubinow D, Doran AR, Breier A, Berrettini WH, Kling MA, Pickar D. Prednisone effects on neurochemistry and behavior. Preliminary findings. Arch Gen Psychiatry. 1990 Oct; 47(10):963-8. PMID: 1977371.
      View in: PubMed
    129. Wolkowitz OM, Gertz B, Weingartner H, Beccaria L, Thompson K, Liddle RA. Hunger in humans induced by MK-329, a specific peripheral-type cholecystokinin receptor antagonist. Biol Psychiatry. 1990 Jul 15; 28(2):169-73. PMID: 2378921.
      View in: PubMed
    130. Pickar D, Breier A, Hsiao JK, Doran AR, Wolkowitz OM, Pato CN, Konicki PE, Potter WZ. Cerebrospinal fluid and plasma monoamine metabolites and their relation to psychosis. Implications for regional brain dysfunction in schizophrenia. Arch Gen Psychiatry. 1990 Jul; 47(7):641-8. PMID: 1694425.
      View in: PubMed
    131. Wolkowitz OM. Use of the dexamethasone suppression test with mentally retarded persons: review and recommendations. Am J Ment Retard. 1990 Mar; 94(5):509-14. PMID: 2180440.
      View in: PubMed
    132. Wolkowitz OM, Papadopoulos NM, Costello R, Breier A, Doran AR, Pickar D, Rubinow D. Prednisone effects on blood-brain barrier permeability and CNS IgG synthesis in healthy humans. Psychoneuroendocrinology. 1990; 15(2):155-8. PMID: 2359811.
      View in: PubMed
    133. Wolkowitz OM, Breier A, Doran A, Lucas P, Kelsoe J, Paul SM, Pickar D. Alprazolam augmentation of neuroleptics in schizophrenia. Am J Psychiatry. 1989 Aug; 146(8):1087-8. PMID: 2568762.
      View in: PubMed
    134. Wolkowitz OM, Doran A, Breier A, Roy A, Pickar D. Specificity of plasma HVA response to dexamethasone in psychotic depression. Psychiatry Res. 1989 Aug; 29(2):177-86. PMID: 2798596.
      View in: PubMed
    135. Bracha HS, Wolkowitz OM, Lohr JB, Karson CN, Bigelow LB. High prevalence of visual hallucinations in research subjects with chronic schizophrenia. Am J Psychiatry. 1989 Apr; 146(4):526-8. PMID: 2929755.
      View in: PubMed
    136. Breier A, Kelsoe JR, Kirwin PD, Beller SA, Wolkowitz OM, Pickar D. Early parental loss and development of adult psychopathology. Arch Gen Psychiatry. 1988 Nov; 45(11):987-93. PMID: 2972265.
      View in: PubMed
    137. Wolkowitz OM, Doran AR, Cohen MR, Cohen RM, Wise TN, Pickar D. Single-dose naloxone acutely reduces eating in obese humans: behavioral and biochemical effects. Biol Psychiatry. 1988 Aug; 24(4):483-7. PMID: 2841988.
      View in: PubMed
    138. Breier A, Wolkowitz OM, Doran AR, Bellar S, Pickar D. Neurobiological effects of lumbar puncture stress in psychiatric patients and healthy volunteers. Psychiatry Res. 1988 Aug; 25(2):187-94. PMID: 2845460.
      View in: PubMed
    139. Sommer BR, Wolkowitz OM. RBC folic acid levels and cognitive performance in elderly patients: a preliminary report. Biol Psychiatry. 1988 Jul; 24(3):352-4. PMID: 3401527.
      View in: PubMed
    140. Wolkowitz OM, Breier A, Doran A, Kelsoe J, Lucas P, Paul SM, Pickar D. Alprazolam augmentation of the antipsychotic effects of fluphenazine in schizophrenic patients. Preliminary results. Arch Gen Psychiatry. 1988 Jul; 45(7):664-71. PMID: 3289524.
      View in: PubMed
    141. Doran AR, Boronow J, Weinberger DR, Wolkowitz OM, Breier A, Pickar D. Structural brain pathology in schizophrenia revisited. Prefrontal cortex pathology is inversely correlated with cerebrospinal fluid levels of homovanillic acid. Neuropsychopharmacology. 1987 Dec; 1(1):25-32. PMID: 3509912.
      View in: PubMed
    142. Lucas PB, Gardner DL, Wolkowitz OM, Cowdry RW. Dysphoria associated with methylphenidate infusion in borderline personality disorder. Am J Psychiatry. 1987 Dec; 144(12):1577-9. PMID: 3688282.
      View in: PubMed
    143. Breier A, Wolkowitz OM, Doran AR, Roy A, Boronow J, Hommer DW, Pickar D. Neuroleptic responsivity of negative and positive symptoms in schizophrenia. Am J Psychiatry. 1987 Dec; 144(12):1549-55. PMID: 3688278.
      View in: PubMed
    144. Breier A, Albus M, Pickar D, Zahn TP, Wolkowitz OM, Paul SM. Controllable and uncontrollable stress in humans: alterations in mood and neuroendocrine and psychophysiological function. Am J Psychiatry. 1987 Nov; 144(11):1419-25. PMID: 2823617.
      View in: PubMed
    145. Wolkowitz OM, Rubinow DR, Breier A, Doran AR, Davis C, Pickar D. Prednisone decreases CSF somatostatin in healthy humans: implications for neuropsychiatric illness. Life Sci. 1987 Oct 19; 41(16):1929-33. PMID: 2889125.
      View in: PubMed
    146. Wolkowitz OM, Weingartner H, Thompson K, Pickar D, Paul SM, Hommer DW. Diazepam-induced amnesia: a neuropharmacological model of an "organic amnestic syndrome". Am J Psychiatry. 1987 Jan; 144(1):25-9. PMID: 3799835.
      View in: PubMed
    147. Amsterdam JD, Henle W, Winokur A, Wolkowitz OM, Pickar D, Paul SM. Serum antibodies to Epstein-Barr virus in patients with major depressive disorder. Am J Psychiatry. 1986 Dec; 143(12):1593-6. PMID: 3024514.
      View in: PubMed
    148. Roy A, Pickar D, Doran A, Wolkowitz O, Gallucci W, Chrousos G, Gold P. The corticotropin-releasing hormone stimulation test in chronic schizophrenia. Am J Psychiatry. 1986 Nov; 143(11):1393-7. PMID: 3022612.
      View in: PubMed
    149. Hommer DW, Matsuo V, Wolkowitz O, Chrousos G, Greenblatt DJ, Weingartner H, Paul SM. Benzodiazepine sensitivity in normal human subjects. Arch Gen Psychiatry. 1986 Jun; 43(6):542-51. PMID: 2871819.
      View in: PubMed
    150. Wolkowitz OM, Doran AR, Breier A, Cohen MR, Pickar D. Endogenous opioid regulation of hypothalamo-pituitary-adrenal axis activity in schizophrenia. Biol Psychiatry. 1986 Apr; 21(4):366-73. PMID: 2869791.
      View in: PubMed
    151. Roy A, Gold P, Pickar D, Wolkowitz OM, Chrousos G, Paul SM. Pre- and post-dexamethasone plasma ACTH levels in depressed patients and normal controls. J Affect Disord. 1986 Mar-Apr; 10(2):95-9. PMID: 3013965.
      View in: PubMed
    152. Wolkowitz OM, Pickar D, Doran AR, Breier A, Tarell J, Paul SM. Combination alprazolam-neuroleptic treatment of the positive and negative symptoms of schizophrenia. Am J Psychiatry. 1986 Jan; 143(1):85-7. PMID: 2867690.
      View in: PubMed
    153. Wolkowitz OM, Sutton ME, Doran AR, Labarca R, Roy A, Thomas JW, Pickar D, Paul SM. Dexamethasone increases plasma HVA but not MHPG in normal humans. Psychiatry Res. 1985 Oct; 16(2):101-9. PMID: 3865250.
      View in: PubMed
    154. Doran AR, Pickar D, Labarca R, Douillet P, Wolkowitz OM, Thomas JW, Roy A, Paul SM. Evidence for a daily rhythm of plasma HVA in normal controls but not in schizophrenic patients. Psychopharmacol Bull. 1985; 21(3):694-7. PMID: 4034886.
      View in: PubMed